Skip to main content
Journal ArticleOPEN ACCESS

HIF1a or HIF2a: Enhancing CD8þ t-cell fitness for antitumor immunity

Cancer Immunology Research (2021) 9(4) 364
DOI: 10.1158/2326-6066.CIR-21-0114
2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Adoptive T-cell therapy requires the transferred lymphocytes to adapt to the hypoxic tumor microenvironment. In this issue, Veli¸ca and colleagues found that modified HIF2a expression in CD8þ T cells increases antitumor efficacy.

References Powered by Scopus

HIF1 α and HIF2 α: sibling rivalry in hypoxic tumour growth and progression

Nature Reviews Cancer
1527Citations
N/AReaders
Get full text

Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype

Cancer Cell
630Citations
N/AReaders
Get full text

Passing the baton: The HIF switch

Trends in Biochemical Sciences
468Citations
N/AReaders
Get full text
View more at Scopus

Cited by Powered by Scopus

CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives

Frontiers in Immunology
22Citations
N/AReaders
Get full text

Surgical stress induced tumor immune suppressive environment

Carcinogenesis
2Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chen, J. (2021). HIF1a or HIF2a: Enhancing CD8þ t-cell fitness for antitumor immunity. Cancer Immunology Research, 9(4), 364. https://doi.org/10.1158/2326-6066.CIR-21-0114

Readers' Seniority

Tooltip

Researcher 2

67%

Professor / Associate Prof. 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

67%

Pharmacology, Toxicology and Pharmaceut... 1

33%

Save time finding and organizing research with Mendeley

Sign up for free